Diabetes Mellitus Clinical Trial
Official title:
An Exercise Programme for People With Severe Peripheral Neuropathy and Diabetic Foot Ulcers - a Case Series on Feasibility and Safety
Verified date | August 2019 |
Source | Københavns Kommune |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Physical training is one of the cornerstones within the treatment of diabetes, as well as
medicine and diet modification, and the effect is well documented. Nevertheless people with
diabetes with foot ulcers are urged to lessen their level of physical activity, to reduce
pressure on footbed and thereby achieve fastest possible healing.
Purpose: The primarily purpose is to investigate the feasibility of implementing safe,
progressive resistance training, combined with exercises for ankle mobility and aerobic
training, for people with diabetes and foot ulcers, without compromising the ulcer. The
secondarily purpose is to investigate whether this form of training is effective on improving
muscle strength, as to if limitations in everyday life diminishes.
The hypothesis is, that it is possible to implement a structured exercise program without
compromising the diabetic ulcer.
Status | Completed |
Enrollment | 5 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients with stable, diabetic ulcer on foot sole in treatment by nurse - who speaks and understands Danish - are able to give consent - are allowed to walk at least short distances - above 18 years old - are able to participate in group exercises Exclusion Criteria: - patients with infection in ulcer - with critical ischemia(<40 mm Hg toe pressure) - not accepted to participate by answering doctor with regards to safety on renal, heart or eye function - dyspnea to an extent, that affects speaking - wheel chair user |
Country | Name | City | State |
---|---|---|---|
Denmark | Rehabilitation Centre Vanloese | Copenhagen | Vanloese |
Lead Sponsor | Collaborator |
---|---|
Københavns Kommune | Copenhagen University Hospital, Hvidovre |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 10 Repetition Maximum (RM)for knee flexor, knee extensor, hip abductor, low row | Change in strength measured by 10 Repetition Maximum(RM) | 10 weeks after entering exercise programme | |
Primary | Patient Specific Functional Scale(PSFS) | Change in ability to perform everyday life tasks, scale from 0-10, 0=can not perform, 10=same level as before ulcer | 10 weeks after entering exercise programme | |
Primary | Endurance cycling on stationary bike | Change in number of km in 12 min | 10 weeks after entering exercise programme | |
Primary | Number of ankle dorsiflexion repetitions | Change in maximum number of repetitions with elastic band | 10 weeks after entering exercise programme | |
Primary | Ulcer area | Change in ulcer area measured in cm2 | 10 weeks after entering exercise programme | |
Secondary | Participant satisfaction measured by Numeric Rating Scale(NRS) | Participant scores satisfaction with programme 0=lowest possible satisfaction 10=highest possible satisfaction | 10 weeks after entering exercise programme |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |